CD19 and rheumatoid arthritis: To determine the ability of CD19+ B cells from untreated RA patients to upregulate PD-L1, we purified CD19+ B cells from PBMC of untreated RA patients and incubated them during 72 h with medium alone or with CpG+IL-2.